S Suraksha Diagnostic Limited: insider trades · India · SEBI (PIT + SAST) SEBI:suraksha-diagnostic-limited IN IN · SEBI (PIT + SAST)
Discover the full management transaction log of Suraksha Diagnostic Limited, a listed equity based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). The latest transaction was reported on 25 February 2026 — Purchase. Among the most active insiders: Dr. Somnath Chatterjee. All data is accessible without an account.
€483,746
17 ops.
Buy Volume
Last declaration on 25 February 2026
Declarations 17 total
Executives ● Purchase0 SEBI
€24,087 9,000 shares @ €2.6763
Equity Shares
SEBI:89302a64f525adfe0bcf284be29f94c6c81e4764 · 25 Feb 2026
Ideal exit: 22 Nov 2026 (T+270) Executives ● Purchase0 SEBI
€16,344 6,234 shares @ €2.6217
Equity Shares
SEBI:e7b995ce3069a98b3490f115e7ccfd01cae751ec · 24 Feb 2026
Ideal exit: 21 Nov 2026 (T+270) Executives ● Purchase0 SEBI
€41,678 15,809 shares @ €2.6363
Equity Shares
SEBI:bbf40ac85d9227a16afa3ce257d1d46417d938dc · 23 Feb 2026
Ideal exit: 20 Nov 2026 (T+270) Executives ● Purchase0 SEBI
€28,928 11,044 shares @ €2.6193
Equity Shares
SEBI:815bbf3b31f1cf91dab19badd605058b11d4afae · 20 Feb 2026
Ideal exit: 17 Nov 2026 (T+270) Executives ● Purchase0 SEBI
€27,289 10,446 shares @ €2.6124
Equity Shares
SEBI:53c2e2362e98babb1eb17a7a449a261f217f0f19 · 19 Feb 2026
Ideal exit: 16 Nov 2026 (T+270) Executives ● Purchase0 SEBI
€15,153 5,800 shares @ €2.6126
Equity Shares
SEBI:ae71843e50aca140d030efdd466e3e1ab7edeed3 · 9 Dec 2025
Ideal exit: 5 Sept 2026 (T+270) Executives ● Purchase0 SEBI
€3,780 1,445 shares @ €2.6162
Equity Shares
SEBI:868b1b72e1b3f7c7eeb3c2a0ce7466de28c3c5d6 · 9 Dec 2025
Ideal exit: 5 Sept 2026 (T+270) Executives ● Purchase0 SEBI
€55,416 19,130 shares @ €2.8968
Equity Shares
SEBI:74fec1e14febb45a459c077d10372bd425e5140c · 29 Sept 2025
Ideal exit: 26 Jun 2026 (T+270) Executives ● Purchase0 SEBI
€24,278 7,800 shares @ €3.1125
Equity Shares
SEBI:2702af98ca8264693354de253dd169d7a7e13197 · 18 Aug 2025
Ideal exit: 15 May 2026 (T+270) Executives ● Purchase0 SEBI
€24,254 8,200 shares @ €2.9578
Equity Shares
SEBI:a94cb3263b821c9d17fe08edea73c81619691f36 · 14 Aug 2025
Ideal exit: 11 May 2026 (T+270) Executives ● Purchase0 SEBI
€24,175 8,235 shares @ €2.9356
Equity Shares
SEBI:d320b3eece4f4cba23e751aa7478f88802c83cb1 · 13 Aug 2025
Ideal exit: 10 May 2026 (T+270) Executives ● Purchase0 SEBI
€24,225 8,190 shares @ €2.9578
Equity Shares
SEBI:4861bc61828bfb8ad20e951cc4fa23dc8abdc617 · 12 Aug 2025
Ideal exit: 9 May 2026 (T+270) Executives ● Purchase0 SEBI
€24,606 7,450 shares @ €3.3028
Equity Shares
SEBI:fcdce8b8e80917842c656f82559feaf30cd1918f · 23 Jun 2025
Ideal exit: 20 Mar 2026 (T+270) Executives ● Purchase0 SEBI
€49,727 15,275 shares @ €3.2555
Equity Shares
SEBI:d8910fcf5fb03f7927cfa6180752bef91aa11706 · 19 Jun 2025
Ideal exit: 16 Mar 2026 (T+270) Executives ● Purchase0 SEBI
€49,749 15,260 shares @ €3.2601
Equity Shares
SEBI:39534079e8ded69677792c529d06f97effb8fe30 · 19 Jun 2025
Ideal exit: 16 Mar 2026 (T+270) Executives ● Purchase0 SEBI
€25,045 7,615 shares @ €3.2889
Equity Shares
SEBI:57d128eae1430486c03495a23736533913c5876f · 18 Jun 2025
Ideal exit: 15 Mar 2026 (T+270) Executives ● Purchase0 SEBI
€25,012 7,590 shares @ €3.2954
Equity Shares
SEBI:57041b52df1adaabb578559bec9f2620aacda8e8 · 13 Jun 2025
Ideal exit: 10 Mar 2026 (T+270)